| Dr Isaac Moss, MD | |
|
Uconn Medical Group, 263 Farmington Ave, Farmington, CT 06030-8082 | |
| (860) 679-6600 | |
| (860) 679-6649 |
| Full Name | Dr Isaac Moss |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 21 Years |
| Location | Uconn Medical Group, Farmington, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013222660 | NPI | - | NPPES |
| 1013222660 | Medicaid | CT |
| Facility Name | Location | Facility Type |
|---|---|---|
| John Dempsey Hospital | Farmington, CT | Hospital |
| Hartford Hospital | Hartford, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Connecticut Health Center | 3678472016 | 523 |
News Archive
How much can a woman lower her risk of breast cancer by losing weight, drinking less, or exercising more? A study published online June 24 in the Journal of the National Cancer Institute describes a new model to estimate the impact of these lifestyle changes on absolute breast cancer risk, suggesting risk reductions that could translate into a substantial number of prevented cancers across an entire population.
"The answer to that question is usually 'no,' but there are exceptions," said Stanford Professor Rob Jackson, a professor of Earth system science at Stanford University, and a senior fellow at the Stanford Woods Institute for the Environment and at the Precourt Institute for Energy.
SEEK, a privately owned biopharmaceutical company specializing in immunology, announces today that it has completed a Phase Ib/II clinical trial of its HIV-v vaccine which demonstrates a one log (approx 90 percent) difference in viral count in HIV-infected people compared with the placebo group, after just a single vaccine injection.
Oncologists are increasingly using information obtained from investigations of the tumor genome in order to find individualized therapies for patients. They specifically search the hereditary information of cancer cells for mutations that drive malignant growth. By now, targeted drugs against many of these cancer-typical cellular alterations have become available.
A mobile platform for lung cancer screening with low-dose computed tomography (CT) can be developed with limited financial risk and take powerful screening tests directly to patients, including underserved rural areas where rates of new lung cancer cases tend to be higher, according to study published today in The Annals of Thoracic Surgery.
› Verified 3 days ago
| Entity Name | University Of Connecticut Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720083769 PECOS PAC ID: 3678472016 Enrollment ID: O20040106000105 |
News Archive
How much can a woman lower her risk of breast cancer by losing weight, drinking less, or exercising more? A study published online June 24 in the Journal of the National Cancer Institute describes a new model to estimate the impact of these lifestyle changes on absolute breast cancer risk, suggesting risk reductions that could translate into a substantial number of prevented cancers across an entire population.
"The answer to that question is usually 'no,' but there are exceptions," said Stanford Professor Rob Jackson, a professor of Earth system science at Stanford University, and a senior fellow at the Stanford Woods Institute for the Environment and at the Precourt Institute for Energy.
SEEK, a privately owned biopharmaceutical company specializing in immunology, announces today that it has completed a Phase Ib/II clinical trial of its HIV-v vaccine which demonstrates a one log (approx 90 percent) difference in viral count in HIV-infected people compared with the placebo group, after just a single vaccine injection.
Oncologists are increasingly using information obtained from investigations of the tumor genome in order to find individualized therapies for patients. They specifically search the hereditary information of cancer cells for mutations that drive malignant growth. By now, targeted drugs against many of these cancer-typical cellular alterations have become available.
A mobile platform for lung cancer screening with low-dose computed tomography (CT) can be developed with limited financial risk and take powerful screening tests directly to patients, including underserved rural areas where rates of new lung cancer cases tend to be higher, according to study published today in The Annals of Thoracic Surgery.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Isaac Moss, MD Uconn Medical Group, 263 Farmington Ave, Farmington, CT 06030-8082 Ph: (860) 679-6600 | Dr Isaac Moss, MD Uconn Medical Group, 263 Farmington Ave, Farmington, CT 06030-8082 Ph: (860) 679-6600 |
News Archive
How much can a woman lower her risk of breast cancer by losing weight, drinking less, or exercising more? A study published online June 24 in the Journal of the National Cancer Institute describes a new model to estimate the impact of these lifestyle changes on absolute breast cancer risk, suggesting risk reductions that could translate into a substantial number of prevented cancers across an entire population.
"The answer to that question is usually 'no,' but there are exceptions," said Stanford Professor Rob Jackson, a professor of Earth system science at Stanford University, and a senior fellow at the Stanford Woods Institute for the Environment and at the Precourt Institute for Energy.
SEEK, a privately owned biopharmaceutical company specializing in immunology, announces today that it has completed a Phase Ib/II clinical trial of its HIV-v vaccine which demonstrates a one log (approx 90 percent) difference in viral count in HIV-infected people compared with the placebo group, after just a single vaccine injection.
Oncologists are increasingly using information obtained from investigations of the tumor genome in order to find individualized therapies for patients. They specifically search the hereditary information of cancer cells for mutations that drive malignant growth. By now, targeted drugs against many of these cancer-typical cellular alterations have become available.
A mobile platform for lung cancer screening with low-dose computed tomography (CT) can be developed with limited financial risk and take powerful screening tests directly to patients, including underserved rural areas where rates of new lung cancer cases tend to be higher, according to study published today in The Annals of Thoracic Surgery.
› Verified 3 days ago
Craig M Rodner, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Uconn Health Center/marb/orthopaedics Associates, Farmington, CT 06030 Phone: 860-679-6600 Fax: 860-679-6604 | |
Robert A Arciero, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Sports Medicine, Farmington, CT 06030 Phone: 860-679-6600 Fax: 860-679-6604 | |
Dr. Cory M Edgar, MD,PHD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Orthopaedics, Farmington, CT 06030 Phone: 860-679-6600 Fax: 860-679-6604 | |
Allison Elizabeth Crepeau, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 399 Farmington Ave Ste 300, Farmington, CT 06032 Phone: 860-837-9220 Fax: 860-837-9221 | |
Kevin P. Shea, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: Uconn Medical Group, 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-6600 Fax: 860-679-6649 | |
Dr. Lauren E Geaney, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: Uconn Medical Group, 263 Farmington Avenue, Farmington, CT 06030 Phone: 860-679-6600 Fax: 860-679-6649 |